ODEVIXIBAT

ODEVIXIBAT was reported 398 times

ODEVIXIBAT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS 2 0.1429
1 BILE ACIDS INCREASED 20 0.1130
2 EXTRA-AXIAL HAEMORRHAGE 1 0.0588
3 BILE ACIDS ABNORMAL 1 0.0455
4 POOR SCHOOL ATTENDANCE 1 0.0400
5 ADENOVIRAL UPPER RESPIRATORY INFECTION 1 0.0345
6 MODEL FOR END STAGE LIVER DISEASE SCORE INCREASED 1 0.0256
7 GASTROENTERITIS ASTROVIRAL 2 0.0250
8 STAPHYLOCOCCAL IMPETIGO 1 0.0179
9 OVERFLOW DIARRHOEA 1 0.0125
10 LEUKODYSTROPHY 1 0.0108
11 VITAMIN K DECREASED 1 0.0106
12 GAMMA-GLUTAMYLTRANSFERASE DECREASED 2 0.0104
13 LIVER TRANSPLANT 36 0.0099
14 TOTAL BILE ACIDS INCREASED 1 0.0068
15 HYPOVITAMINOSIS 8 0.0060
16 ANAL INJURY 1 0.0058
17 SUSPECTED DRUG-INDUCED LIVER INJURY 1 0.0050
18 WITHDRAWAL HYPERTENSION 1 0.0050
19 STOMA SITE DISCOMFORT 1 0.0044
20 INCREASED INSULIN REQUIREMENT 1 0.0042
21 HYPONATRAEMIC SEIZURE 1 0.0039
22 GONORRHOEA 1 0.0037
23 PRODUCT INFORMATION CONTENT COMPLAINT 1 0.0036
24 BILE ACID MALABSORPTION 1 0.0035
25 HEPATIC CANCER RECURRENT 1 0.0035
26 COAGULATION TIME ABNORMAL 1 0.0033
27 LIVER OPERATION 1 0.0032
28 STOMA CLOSURE 1 0.0032
29 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0027
30 BILIRUBIN CONJUGATED INCREASED 6 0.0026
31 VITAMIN K DEFICIENCY 1 0.0025
32 CHOLESTASIS OF PREGNANCY 1 0.0022
33 METAPLASIA 1 0.0021
34 PRODUCT DOSAGE FORM ISSUE 1 0.0021
35 HYPERSPLENISM 1 0.0020
36 POST PROCEDURAL DIARRHOEA 1 0.0020
37 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 1 0.0019
38 PORTAL HYPERTENSIVE GASTROPATHY 1 0.0018
39 ENTERAL NUTRITION 1 0.0017
40 TRANSAMINASES ABNORMAL 1 0.0017
41 BLOOD BILIRUBIN DECREASED 1 0.0016
42 POST PROCEDURAL INFLAMMATION 1 0.0016
43 HYPERCHLORAEMIA 1 0.0016
44 BLOOD BILIRUBIN ABNORMAL 2 0.0016
45 SCLERAL DISCOLOURATION 1 0.0015
46 FOETAL HYPOKINESIA 1 0.0014
47 ALPHA 1 FOETOPROTEIN INCREASED 1 0.0014
48 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
49 PRODUCT INEFFECTIVE 1 0.0013
50 CROUP INFECTIOUS 1 0.0013
51 BLOOD FIBRINOGEN INCREASED 1 0.0013
52 ENTEROVIRUS INFECTION 1 0.0012
53 COLOUR BLINDNESS 1 0.0011
54 INTUSSUSCEPTION 1 0.0010
55 ILEAL ULCER 1 0.0010
56 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
57 STRESS AT WORK 1 0.0009
58 CARBON DIOXIDE DECREASED 1 0.0009
59 BLOOD BILIRUBIN INCREASED 22 0.0008
60 OBSTRUCTION GASTRIC 1 0.0008
61 ADJUSTMENT DISORDER 1 0.0008
62 DIABETIC FOOT INFECTION 1 0.0007
63 INVESTIGATION ABNORMAL 1 0.0007
64 VOMITING PROJECTILE 2 0.0007
65 PORTAL HYPERTENSION 2 0.0006
66 TESTICULAR PAIN 2 0.0006
67 TRANSAMINASES INCREASED 14 0.0006
68 TYMPANIC MEMBRANE PERFORATION 1 0.0006
69 ACUTE SINUSITIS 1 0.0006
70 AORTIC VALVE STENOSIS 1 0.0006
71 JAUNDICE 15 0.0006
72 PRODUCT RESIDUE PRESENT 3 0.0006
73 DYSENTERY 1 0.0005
74 UNDERWEIGHT 1 0.0005
75 EAR HAEMORRHAGE 1 0.0005
76 ANAL PRURITUS 1 0.0005
77 OCULAR ICTERUS 2 0.0005
78 MIDDLE EAR EFFUSION 1 0.0005
79 FAECES PALE 1 0.0004
80 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
81 SKIN ABRASION 2 0.0004
82 INTENTIONAL UNDERDOSE 3 0.0004
83 HEPATOMEGALY 4 0.0004
84 MUCOUS STOOLS 2 0.0004
85 HEPATIC ENZYME ABNORMAL 2 0.0004
86 HEPATOCELLULAR CARCINOMA 3 0.0004
87 HEPATOSPLENOMEGALY 1 0.0004
88 SCRATCH 4 0.0004
89 BLOOD SODIUM INCREASED 1 0.0004
90 HEPATIC ENZYME INCREASED 25 0.0004
91 SUBDURAL HAEMORRHAGE 1 0.0004
92 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
93 THERAPEUTIC RESPONSE DELAYED 1 0.0004
94 SOCIAL AVOIDANT BEHAVIOUR 2 0.0003
95 BILIARY COLIC 1 0.0003
96 SPLENOMEGALY 4 0.0003
97 GROWTH RETARDATION 1 0.0003
98 VARICES OESOPHAGEAL 1 0.0003
99 LIVER FUNCTION TEST INCREASED 7 0.0003
100 ALANINE AMINOTRANSFERASE INCREASED 20 0.0003
101 CHOLANGITIS 2 0.0003
102 HEPATIC CIRRHOSIS 6 0.0003
103 BILE DUCT STONE 1 0.0003
104 HEPATIC FIBROSIS 1 0.0003
105 DEFAECATION URGENCY 2 0.0003
106 ASPARTATE AMINOTRANSFERASE INCREASED 15 0.0003
107 MACULOPATHY 1 0.0003
108 APPENDICECTOMY 1 0.0003
109 PRODUCT SUPPLY ISSUE 2 0.0003
110 RENAL TRANSPLANT 1 0.0003
111 PRURITUS 106 0.0003
112 FAECES SOFT 2 0.0003
113 PROTEIN TOTAL DECREASED 1 0.0003
114 PRODUCT STORAGE ISSUE 1 0.0003
115 RHINOVIRUS INFECTION 1 0.0003
116 SKIN ODOUR ABNORMAL 1 0.0003
117 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
118 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
119 SLEEP TERROR 1 0.0002
120 HEPATIC PAIN 1 0.0002
121 VITAMIN D DECREASED 2 0.0002
122 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
123 IRON DEFICIENCY 1 0.0002
124 HEAVY MENSTRUAL BLEEDING 2 0.0002
125 DISEASE COMPLICATION 1 0.0002
126 YELLOW SKIN 1 0.0002
127 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
128 CHOLESTASIS 4 0.0002
129 INCORRECT DOSAGE ADMINISTERED 1 0.0002
130 FLUID INTAKE REDUCED 1 0.0002
131 MALABSORPTION 1 0.0002
132 BLOOD LACTIC ACID INCREASED 1 0.0002
133 DECREASED ACTIVITY 2 0.0002
134 GASTROINTESTINAL PAIN 2 0.0002
135 COAGULOPATHY 3 0.0002
136 HEPATOTOXICITY 4 0.0002
137 MALNUTRITION 2 0.0002
138 PERIORBITAL SWELLING 1 0.0002
139 NEUROLOGICAL SYMPTOM 1 0.0002
140 LIVER FUNCTION TEST ABNORMAL 5 0.0002
141 PRODUCT LABEL CONFUSION 1 0.0002
142 HYPERCHLORHYDRIA 1 0.0002
143 HEPATIC FAILURE 5 0.0002
144 HEPATIC STEATOSIS 3 0.0002
145 PRE-EXISTING CONDITION IMPROVED 1 0.0002
146 BLOOD SODIUM DECREASED 3 0.0002
147 DIARRHOEA 99 0.0002
148 PRODUCT PREPARATION ISSUE 1 0.0002
149 TERMINAL STATE 1 0.0001
150 TREATMENT NONCOMPLIANCE 8 0.0001
151 AUTOIMMUNE HEPATITIS 1 0.0001
152 POOR QUALITY SLEEP 3 0.0001
153 FAECES DISCOLOURED 3 0.0001
154 GASTROENTERITIS 2 0.0001
155 HEPATIC FUNCTION ABNORMAL 5 0.0001
156 ACIDOSIS 1 0.0001
157 BOWEL MOVEMENT IRREGULARITY 1 0.0001
158 PROCEDURAL COMPLICATION 1 0.0001
159 PRODUCT USE COMPLAINT 2 0.0001
160 RENAL CYST 1 0.0001
161 TRICUSPID VALVE INCOMPETENCE 1 0.0001
162 TRANSPLANT REJECTION 1 0.0001
163 ABDOMINAL PAIN UPPER 25 0.0001
164 VIRAL INFECTION 4 0.0001
165 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
166 LUNG INFILTRATION 1 0.0001
167 GASTROINTESTINAL INFECTION 1 0.0001
168 ANAL INCONTINENCE 1 0.0001
169 DEVELOPMENTAL DELAY 1 0.0001
170 HEPATIC ENCEPHALOPATHY 1 0.0001
171 APPENDICITIS 1 0.0001
172 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
173 PRODUCT PACKAGING ISSUE 1 0.0001
174 ACUTE RESPIRATORY FAILURE 2 0.0001
175 DIZZINESS POSTURAL 1 0.0001
176 THERAPY CHANGE 1 0.0001
177 KNEE OPERATION 1 0.0001
178 LABORATORY TEST ABNORMAL 3 0.0001
179 HELICOBACTER INFECTION 1 0.0001
180 TRANSFUSION 1 0.0001
181 INCONTINENCE 1 0.0001
182 ABDOMINAL PAIN 22 0.0001
183 IRRITABLE BOWEL SYNDROME 2 0.0001
184 SKIN LACERATION 1 0.0001
185 PRODUCT DOSE OMISSION ISSUE 27 0.0001
186 CHOLELITHIASIS 3 0.0001
187 OFF LABEL USE 79 0.0001
188 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
189 THERAPY NON-RESPONDER 4 0.0001
190 MITRAL VALVE INCOMPETENCE 1 0.0001
191 SCAB 1 0.0001
192 METASTASES TO LUNG 1 0.0001
193 HEPATIC CANCER 2 0.0001
194 PHARYNGITIS 1 0.0001
195 TOOTH EXTRACTION 1 0.0001
196 COLITIS 3 0.0001
197 HEPATITIS 2 0.0001
198 DIPLOPIA 2 0.0001
199 ORAL CANDIDIASIS 1 0.0001
200 TOOTH INFECTION 1 0.0001
201 PANCREATITIS 4 0.0001
202 PRODUCT TASTE ABNORMAL 1 0.0001
203 INFLUENZA 8 0.0001
204 BLOOD TEST ABNORMAL 1 0.0001
205 ACCIDENTAL UNDERDOSE 1 0.0001
206 ASCITES 2 0.0001
207 LIVER DISORDER 3 0.0001
208 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
209 BLOOD POTASSIUM DECREASED 2 0.0001
210 INSURANCE ISSUE 1 0.0001
211 LYMPHOMA 1 0.0001
212 TENDONITIS 1 0.0001
213 DRUG LEVEL INCREASED 1 0.0001
214 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
215 DISEASE PROGRESSION 7 0.0001
216 SCAR 1 0.0001
217 ILLNESS 6 0.0001
218 COLD SWEAT 1 0.0001
219 GASTROENTERITIS VIRAL 1 0.0001
220 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
221 ABDOMINAL DISCOMFORT 9 0.0001
222 MIDDLE INSOMNIA 1 0.0001
223 PRODUCT USE ISSUE 10 0.0001
224 FLATULENCE 3 0.0001
225 DEHYDRATION 7 0.0001
226 INCREASED APPETITE 1 0.0001
227 DRUG INTOLERANCE 5 0.0001
228 HERNIA 1 0.0001
229 EAR PAIN 1 0.0001
230 IRRITABILITY 3 0.0000
231 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
232 PRODUCT ADMINISTRATION ERROR 1 0.0000
233 FEEDING DISORDER 1 0.0000
234 POLLAKIURIA 2 0.0000
235 EATING DISORDER 1 0.0000
236 RETCHING 1 0.0000
237 IMPAIRED WORK ABILITY 1 0.0000
238 PRODUCT DISPENSING ERROR 1 0.0000
239 MELAENA 1 0.0000
240 SEPSIS 5 0.0000
241 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
242 GASTROINTESTINAL DISORDER 4 0.0000
243 MUSCLE TWITCHING 1 0.0000
244 PERICARDIAL EFFUSION 1 0.0000
245 VOMITING 20 0.0000
246 SLEEP DISORDER 3 0.0000
247 MENTAL IMPAIRMENT 1 0.0000
248 UNDERDOSE 3 0.0000
249 LIVER INJURY 1 0.0000
250 EPISTAXIS 3 0.0000
251 AGEUSIA 1 0.0000
252 ABDOMINAL PAIN LOWER 1 0.0000
253 HAEMATEMESIS 1 0.0000
254 RESPIRATORY TRACT INFECTION 1 0.0000
255 DEAFNESS 1 0.0000
256 EAR INFECTION 1 0.0000
257 FREQUENT BOWEL MOVEMENTS 1 0.0000
258 SKIN LESION 1 0.0000
259 HAEMATOCHEZIA 2 0.0000
260 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
261 WEIGHT DECREASED 10 0.0000
262 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
263 INTENTIONAL DOSE OMISSION 1 0.0000
264 INTENTIONAL PRODUCT MISUSE 3 0.0000
265 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
266 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
267 RENAL INJURY 1 0.0000
268 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
269 THERAPEUTIC RESPONSE DECREASED 2 0.0000
270 EPILEPSY 1 0.0000
271 FEELING HOT 2 0.0000
272 HOSPITALISATION 5 0.0000
273 EXPOSURE DURING PREGNANCY 2 0.0000
274 CONSTIPATION 7 0.0000
275 DRUG-INDUCED LIVER INJURY 1 0.0000
276 HYPOTHYROIDISM 1 0.0000
277 WEIGHT INCREASED 7 0.0000
278 FUNGAL INFECTION 1 0.0000
279 SKIN DISORDER 1 0.0000
280 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
281 DRUG INEFFECTIVE 39 0.0000
282 SINUSITIS 3 0.0000
283 HAEMATURIA 1 0.0000
284 ABDOMINAL DISTENSION 3 0.0000
285 HAEMORRHAGE 3 0.0000
286 CRYING 1 0.0000
287 C-REACTIVE PROTEIN INCREASED 1 0.0000
288 AGITATION 2 0.0000
289 BLINDNESS 1 0.0000
290 RECTAL HAEMORRHAGE 1 0.0000
291 SEPTIC SHOCK 1 0.0000
292 INSOMNIA 6 0.0000
293 DRY SKIN 3 0.0000
294 INCORRECT DOSE ADMINISTERED 5 0.0000
295 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
296 DECREASED APPETITE 5 0.0000
297 ANAEMIA 4 0.0000
298 BLOOD GLUCOSE DECREASED 1 0.0000
299 HYPOGLYCAEMIA 1 0.0000
300 ALOPECIA 4 0.0000
301 DYSPEPSIA 2 0.0000
302 PYREXIA 7 0.0000
303 NAUSEA 16 0.0000
304 MUSCULOSKELETAL PAIN 1 0.0000
305 DEPRESSED MOOD 1 0.0000
306 OEDEMA 1 0.0000
307 MEDICATION ERROR 1 0.0000
308 BLISTER 1 0.0000
309 BONE PAIN 1 0.0000
310 NASAL CONGESTION 1 0.0000
311 ILL-DEFINED DISORDER 1 0.0000
312 PLEURAL EFFUSION 1 0.0000
313 RHINORRHOEA 1 0.0000
314 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
315 SKIN BURNING SENSATION 1 0.0000
316 UNEVALUABLE EVENT 1 0.0000
317 ACUTE KIDNEY INJURY 2 0.0000
318 PERIPHERAL SWELLING 2 0.0000
319 URTICARIA 2 0.0000
320 RENAL IMPAIRMENT 1 0.0000
321 PRODUCT STORAGE ERROR 1 0.0000
322 HEADACHE 7 0.0000
323 ADVERSE DRUG REACTION 1 0.0000
324 SUICIDAL IDEATION 1 0.0000
325 MUSCLE SPASMS 2 0.0000
326 ADVERSE EVENT 1 0.0000
327 OROPHARYNGEAL PAIN 1 0.0000
328 COUGH 3 0.0000
329 CARDIAC DISORDER 1 0.0000
330 CONTUSION 1 0.0000
331 FATIGUE 8 0.0000
332 HEART RATE INCREASED 1 0.0000
333 CONDITION AGGRAVATED 3 0.0000
334 HAEMOGLOBIN DECREASED 1 0.0000
335 DEATH 8 0.0000
336 PNEUMONIA 3 0.0000
337 THROMBOCYTOPENIA 1 0.0000
338 ASTHMA 1 0.0000
339 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
340 FEELING ABNORMAL 2 0.0000
341 OEDEMA PERIPHERAL 1 0.0000
342 ASTHENIA 3 0.0000
343 LOSS OF CONSCIOUSNESS 1 0.0000
344 VISION BLURRED 1 0.0000
345 ANXIETY 2 0.0000
346 INFECTION 1 0.0000
347 MALAISE 3 0.0000
348 HYPOAESTHESIA 1 0.0000
349 BLOOD PRESSURE INCREASED 1 0.0000
350 CONFUSIONAL STATE 1 0.0000
351 TREMOR 1 0.0000
352 CEREBROVASCULAR ACCIDENT 1 0.0000
353 URINARY TRACT INFECTION 1 0.0000
354 COVID-19 1 0.0000
355 HYPERSENSITIVITY 1 0.0000
356 BLOOD GLUCOSE INCREASED 1 0.0000
357 GAIT DISTURBANCE 1 0.0000
358 SOMNOLENCE 1 0.0000
359 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
360 PAIN 3 0.0000
361 DEPRESSION 1 0.0000
362 BACK PAIN 1 0.0000
363 DIZZINESS 2 0.0000
364 FALL 1 0.0000
365 ARTHRALGIA 1 0.0000